跳转至内容
Merck

G004432

HPLC Analysis of Statins in Rat Plasma on Ascentis® Express C18 after SPE using Supel-Select HLB

application for SPE, application for LC-MS

登录查看公司和协议定价


About This Item

技術

LC/MS: suitable
solid phase extraction (SPE): suitable

測試參數

sample preparation: SPE (Solid Phase Extraction)
sample/matrix: rat plasma spiked with provastin and atorvastin at 5 and 100 ng/mL
SPE tube/cartridge: Supel-Select HLB SPE, 30 mg/1 mL (54181-U)
condition: 0.5 mL methanol:acetonitrile (1:1, v/v); 0.5 mL DI water
sample addition: 0.5 mL
washing: 0.5 mL 5% methanol
elution: 0.5 mL methanol:acetonitrile (1:1, v/v)
column: Ascentis Express C18, 5 cm x 2.1 mm, 2.7 μm particles (53822-U)
eluate post-treatment: evaporate to dryness with nitrogen at 37 °C, reconstitute in 0.5 mL DI water
mobile phase: 0.1% acetic acid diluted in 60% methanol
flow rate: 0.2 mL/min
column temp.: 35 °C
detector: ABI 3200 QT; ESI(+), MRM (423.3/321.3, 423.3/101.0, 557.3/397.2 and 557.3/453.4)
injection: 5 μL

適合性

application for LC-MS
application for SPE

應用

clinical

法律資訊

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Supel is a trademark of Sigma-Aldrich Co. LLC

Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门